Skip to main content
Equibles

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1086619 London, X0
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$77,262,797
-$54,550,453 QoQ
Shares Held
2,280,484
-47.9% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#53
of 675 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $225,719,959 across 11 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (34.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page 		2,280,484 $77,262,797
2 UTHR
UNITED THERAPEUTICS Corp
 72,306 $39,177,559
3 HIMS
Hims & Hers Health, Inc.
 1,129,781 $39,169,506
4 RDY
Dr Reddys Laboratories Ltd
 1,618,404 $23,450,672
5 SUPN
Supernus Pharmaceuticals, Inc.
 368,017 $17,116,470
6 HCM
HUTCHMED (China) Ltd
 1,477,494 $15,897,835
7 ELAN
Elanco Animal Health Inc
 333,656 $8,211,273
8 NBIX
Neurocrine Biosciences Inc
 16,253 $2,739,280

All Filings in TEVA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $77,262,797 2,280,484
2026-03-31 $131,813,250 4,376,270
2025-12-31 $231,793,076 7,426,885
2025-09-30 $41,543,965 2,056,632
2025-06-30 $34,451,319 2,055,568
2025-03-31 $34,651,695 2,254,502
2024-12-31 $49,144,483 2,229,786
2024-09-30 $16,392,974 909,710
2024-06-30 $16,693,787 1,027,310
2024-03-31 $12,045,213 853,665
2023-12-31 $6,343,229 607,589
2022-12-31 $339,063 37,178
2022-09-30 $180,759 22,399
2022-06-30 $2,974,017 395,481
2022-03-31 $6,660,570 709,326
2021-12-31 $5,629,644 702,827
2021-09-30 $7,063,826 725,239
2021-06-30 $7,160,372 723,270
2021-03-31 $359,390 31,143
2020-03-31 $13,362 1,488